Souhil Zaim

No ORCID on file · 2 papers in corpus · active 2023-2025

Study types

  • article 1
  • rct 1

Condition tags

  • adenomyosis 2
  • endometriosis 1
rct 2025
Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: subgroup analysis of LIBERTY 1 and LIBERTY 2
Fertility and sterility ·doi:10.1016/j.fertnstert.2025.04.037

OBJECTIVE: To assess the effects of relugolix combination therapy in women with uterine fibroids (UFs) and concomitant ultrasound-diagnosed adenomyosis. DESIGN: This post hoc analysis used pooled data from completers of the pivotal LIBERTY…

article 2023
Relugolix Combination Therapy in Women With Uterine Fibroids and Adenomyosis: LIBERTY 1 and 2 Trials [ID: 1345355]
·doi:10.1097/01.aog.0000929840.36823.a1

INTRODUCTION: Adenomyosis and uterine fibroids (UFs) may coexist in women with heavy menstrual bleeding (HMB). Relugolix combination therapy (Relugolix-CT: relugolix 40 mg, estradiol 1 mg, norethindrone acetate 0.5 mg) is approved in the Un…